Developing doctoral scientists for drug discovery: pluridimensional education required.

Area of Science:

• Biomedical Sciences
• Drug Discovery and Development
• Graduate Education

Background:

• Doctoral science students show interest in therapeutics research but lack practical drug discovery and commercialization experience.
• The traditional academic system (PI-stan) often overlooks the development of "beyond-the-bench" professional skills vital for therapeutics innovation.
• This can lead to a deficit in professionalization for future drug discovery researchers.

Discussion:

• The current academic model risks commoditizing doctoral students as labor, hindering their preparation for careers in therapeutics innovation.
• There's a critical need for graduate education to incorporate pluridimensionality, extending beyond scientific domains and lab techniques.
• Mentorship should focus on developing transferable skills like operational intelligence, project/people management, and communication.

Key Insights:

• Academic training must evolve to equip doctoral students with essential professional competencies for modern drug discovery.
• Integrating business acumen and project management into graduate curricula is vital for career adaptability.
• Bridging the gap between academic research and the commercial drug development landscape is paramount.

Outlook:

• Implementing specific initiatives can enhance doctoral students' market competitiveness in preclinical drug discovery R&D.
• Improved graduate education will better prepare scientists to navigate the complexities of research, commercialization, and occupational challenges.
• This approach fosters a more adaptable and skilled workforce for the future of therapeutics innovation.